ANI Pharmaceuticals announces a SEK 5.6-billion offer for Egetis Therapeutics, adding rare disease drug Emcitate to its ...
Novartis confirms nine tumour reports in Zolgensma-treated patients, with two showing evidence of gene-therapy vector ...
MedPharm appoints Jason Mieding as COO to lead operations at its Durham facility and support manufacturing expansion.
The hospital chain records 42.5% YoY EBITDA growth, while its newer Srinagar and Kanpur hospitals more than double their ...
Delhi CM Rekha Gupta outlines healthcare expansion through hospital upgrades, increased medical seats, Ayushman coverage and ...
Pfizer appoints Cecile Guegan as CFO and Executive Vice President, bringing over 25 years of pharmaceutical finance ...
Boehringer Ingelheim and SBP Group partner on six ADC and T-cell engager programmes, with potential milestone payments of up ...
ANVISA authorises the diabetes treatment, with Dr Reddy’s planning a Brazilian launch in partnership with Aché as the company ...
Lupin launches Raltegravir 600 mg tablets in the US after FDA approval, with eligibility for 180-day generic e.
Shilpa CDMO will invest $50 million to add 10 kL of SPPS capacity at its Raichur facility, with its first commercial line ...
TRANSFORM II finds sirolimus-coated balloons non-inferior to drug-eluting stents at 12 months in patients with de novo ...
Terumo India Skill Lab and SMS Jaipur host MASTR KAIZEN, a simulation-based programme to train young cardiologists in complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results